https://nypost.com/2023/06/12/fda-approves-dementia-drug-that-slows-cognitive-decline/
0
0
6/12/23 at 5:19pm
Organization
New York Post
Author
Marc Lallanilla
Lecanemab, marketed as Leqembi, could be a game-changer for people with Alzheimer’s disease — but only if they can get it.
Create an account
or login to join the discussion